The future of immuno-oncology in kidney cancer
In his keynote lecture at the American Society for Clinical [...]
In his keynote lecture at the American Society for Clinical [...]
Today, the National Institute for Health and Care Excellence (NICE) have recommended tivozanib (Fotivda) [...]
As part of NHS England's Five-Year Forward View and recent [...]
Results from a phase 1 clinical trial looking at CB-839, [...]
The combination of immunotherapy atezolizumab (Tecentriq) with targeted therapy bevacizumab [...]
Data from the phase 3 METEOR trial published in the Journal [...]
A new global study involving 37 million cancer patients in [...]
Data from a pooled analysis published in the journal Cancer [...]
Baroness Tessa Jowell received a standing ovation after delivering moving [...]
An NHS England press release, published on Christmas Eve, reports [...]